The pharma sector in the MENA region has witnessed rapid development, which has been largely fueled by high population growth, increased life expectancy coupled with the prevalence of lifestyle-related diseases such as diabetes, aspiration for excellent healthcare services and the rising cost of healthcare which is expected to reach US$60 billion by the year 2025.

The Middle East Pharma Cold Chain Congress is the main platform for the pharmaceutical industry in the MENA region which gathers all the industry stakeholders to converge; discuss ongoing and future challenges and come up with solutions to address these issues. This year, the focus is on pharmaceutical companies in the Middle East and North Africa (MENA) facing several challenges such as globalisation of the pharmaceutical supply chain, developing GDP regulations updates and maintaining global compliance for temperature-sensitive pharmaceuticals across different countries with varying regulations.

This year’s congress places emphasis on overcoming these challenges with the most effective strategies including regulatory compliance, integrating cold chain management, selecting the appropriate partners, maintaining supply chain integrity, achieving real time traceability and more.